Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
27.96
-1.10 (-3.79%)
Oct 6, 2026, 4:00 PM EDT - Market closed
Biodesix Employees
Biodesix had 334 employees as of December 31, 2025. The number of employees increased by 61 or 22.34% compared to the previous year.
Employees
334
Change (1Y)
61
Growth (1Y)
22.34%
Revenue / Employee
$308,201
Profits / Employee
-$83,120
Market Cap
295.01M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 334 | 61 | 22.34% |
| Dec 31, 2024 | 273 | 56 | 25.81% |
| Dec 31, 2023 | 217 | -28 | -11.43% |
| Dec 31, 2022 | 245 | 27 | 12.39% |
| Dec 31, 2021 | 218 | 18 | 9.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Myriad Genetics | 2,700 |
| OPKO Health | 2,275 |
| Fulgent Genetics | 1,315 |
| Castle Biosciences | 1,002 |
| Burning Rock Biotech | 667 |
| Freenome | 381 |
| MDxHealth | 364 |
| Personalis | 260 |
BDSX News
- 11 days ago - Biodesix price target raised to $38 from $27 at H.C. Wainwright - TheFly
- 12 days ago - Biodesix advances two programs for Molecular Residual Disease monitoring - TheFly
- 12 days ago - Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring - GlobeNewsWire
- 22 days ago - Biodesix Quality and Regulatory Executive, Brianna Phillips, to speak at upcoming RAPS and SOCRA Annual Meetings - GlobeNewsWire
- 4 weeks ago - Biodesix to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 7 weeks ago - Biodesix Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
- 1 month ago - Biodesix price target raised to $35 from $27 at Canaccord - TheFly
- 2 months ago - Biodesix price target raised to $27 from $26 at H.C. Wainwright - TheFly